![](https://static.timesofisrael.com/www/uploads/2022/09/cytoreason-founders.jpg)
Backed by Nvidia and Pfizer, Israeli AI medical startup raises $80m in fresh capital
CytoReason, an Israeli startup that uses artificial intelligence to develop computational disease models for drug discovery, said Wednesday it has secured $80 million in a private funding round backed by US chipmaker Nvidia and pharma giant Pfizer. The …